Registration Open
 | | The COVID-19 pandemic has fundamentally changed the way people live and work around the world. There is a huge demand to expand the diagnostic capacity. | Sino Biological's Novel COVID-19 Immunodiagnostic webinar series provides a platform where new technologies can be shared among research and industrial leaders. The invited speakers are industrial and academic scientists working on a variety of novel diagnostic assays. The scope of the webinars includes assays that:
1. detect the virus itself, or viral antigens, with high specificity and sensitivity
2. can allow high-throughput testing
3. can simultaneously detect multiple antigens and/or antibodies
4. use different detection systems than colloidal gold | Registration:
The webinars will take place from 7/21/2020 to 8/13/2020. To register, please click the "register" button below to get the entry link. All webinars will be held on ZOOM. | | | | | | Analyzing the Human Antibody Response to Pandemic Respiratory Viruses with Adarza's New ZIVA™ Platform and High Definition Antigen Arrays: A Case Study on COVID-19 | |  | Benjamin Miller, Ph.D. | | | Founder, Adarza Biosystems
Dean's Professor of Dermatology, Biochemistry and Biophysics, Biomedical Engineering, and Optics, University of Rochester | | | | | | | Cytokine Biomarkers of Inflammatory Response in COVID-19 Patients | |  | Left: Kevin Hrusovsky
President, Chairman and CEO, Quanterix
Right: Dan Sikkema, Ph.D.
Vice President, Accelerator and Pharma Services, Quanterix |
 | Darragh Duffy, Ph.D.
Scientific Manager
LabEx Milieu Interieur, Institut Pasteur |
| | | | | | | Microfluidic, Nanoliter-scale Immunoassays for Rapid SARS-CoV-2 Antibody Analysis in Serology Testing, and Vaccine and Biotherapeutics Development | |  | Rob Durham, Ph.D. | | | Director of Service and Scientific Support
Gyros Protein Technologies | | | | | | | Rapid and Quantitative Detection of SARS-CoV-2 Specific IgG for Convalescent Plasma Therapy | |  | Xiaotian Tan, Ph.D. | | | Research Fellow
University of Michigan | | | | | | | Frequency of Direct Antigen Rapid Testing for COVID-19 Reduces Transmission | |  | Bobby Brooke Herrera, Ph.D. | | | Co-founder & Interim CEO, CSO, E25Bio, Inc.
Visiting Scientist, Harvard T.H. Chan School of Public Health | | | | | | | High-Accuracy Multiplexed SARS-CoV-2 Antibody Assay with Avidity and Saliva Capability on a Nano-Plasmonic Platform | | Left: Meijie Tang, Ph.D.
CEO, Nirmidas Biotech Inc.
Right: Hongjie Dai, Ph.D.
Professor, Department of Chemistry and Bio-X, Stanford University | | | | | | | | Next Generation BLI: Novel Applications in the Fight against COVID-19 | |  | Kathryn E Livingston, Ph.D. | | | Product Manager
Gator Bio | | | | | | |  | Point of Care Systems for COVID-19 and Other Diseases (TBD) | | | Victor Manneh, Ph.D. | | | Chief Scientific Officer
Xen BiofluiDx Inc. | | | | | |
© Future US, Inc., 11 W 42nd Street, 15th Floor, New York, NY 10036
This email is intended for znamenski.astronomy@blogger.com
To unsubscribe from LiveScience emails, or update your email preferences please click here
We've updated our Privacy Policy. The updates include additional information we have added in response to the California Consumer Privacy Act. The updated policy is effective as of January 2020. We encourage you to read the complete updated Privacy Policy here.
View our Terms and Conditions here
| | |
No comments:
Post a Comment